전남대학교 중앙도서관

  • 중앙도서관
  • 여수캠퍼스도서관
  • 법학도서관
  • 치의학도서관
  • 의학도서관

링크메뉴

  • 화면키우기 화면줄이기 화면크기 원래대로
  • S
  • HOME
  • 로그인
  • 전남대
  • ENG
  • CHN

주메뉴

전체메뉴

전자자료 상세검색

전자자료 상세검색

통합검색
상세검색
검색어 [키워드: "Van Nostrand, S."]
총 6건 
※ 중복 레코드가 제거된 검색 결과가 표시됩니다.
1/1 페이지 RSS 엑셀파일 출력
검색결과수정
  • 검색범위확장
    • Full Text내 키워드 확장
    • 관련 주제어 확장

    재검색

  • 검색결과제한
    • 원문(Full Text)
    • Peer-Reviewed 학술지
    • 발행년 -

    재검색

  • 자료유형
    • Academic Journals (6)
    • Reviews (1)
    • Magazines (1)

    재검색

  • 주제
    • feeding (2)
    • gestational age (2)
    • hemorrhage (2)

    더보기

    재검색

  • 간행물
    • journal of neonatal - perinatal medicine (2)
    • pm world journal (2)
    • cancer cell (1)

    더보기

    재검색

  • 출판사
    • ios press (3)
    • pm world inc. (2)
    • american academy of pediatrics (1)

    더보기

    재검색

  • 언어
    • english (8)

    재검색

  • Publication Year
    • 2015 (1)
    • 2016 (1)

    재검색

  • 수록데이터베이스
    • MEDLINE (4)
    • Complementary Index (2)
    • Academic Search Complete (1)

    더보기

    재검색

  • PQDTSearch
  • CAJSearch
  • RISSSearch
  • PsycINFOSearch

 

출판물 검색결과(총 2건)

1. Van Nostrand's Engineering Magazine (1879-1886)

전문(Full Text) 제공 DB / 패키지 :

2. Van Nostrand's Eclectic Engineering Magazine (1869-1879)

전문(Full Text) 제공 DB / 패키지 :

더보기

펼치기 닫기
2
Factors influencing independent oral feeding in preterm infants. 미리보기

학술저널

issue
Journal of Neonatal - Perinatal Medicine. 2015, Vol. 8 Issue 1, p15-21. 7p. 4 Charts.
Author
Van Nostrand, S. M.1
Bennett, L. N.1
Coraglio, V. J.1
Guo, R.2
Muraskas, J. K.1 jmurask@lumc.edu
DB Label
Database : Academic Search Complete
원문보기
Full Text Full Text (원문보기) 등재 - SCOPUS 
3
Secrets to Mastering the WBS in Real World Projects, second edition. 미리보기

리뷰

issue
PM World Journal. Oct2016, Vol. 5 Issue 10, p1-4. 4p.
Author
Van Nostrand, S. Lance1 lance.vannostrand@gmail.com
DB Label
Database : Business Source Complete
원문보기
4
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial. 미리보기

학술저널

issue
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Apr 15; Vol. 30 (8), pp. 1655-1668.
Author
Parra ER; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Zhang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Duose DY; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gonzalez-Kozlova E; Department of Oncological Sciences, Mount Sinai, New York, New York.; Tisch Cancer Institute, Mount Sinai, New York, New York.; Precision Immunology Institute, Mount Sinai, New York, New York.; Icahn School of Medicine at Mount Sinai, New York, New York.
Redman MW; SWOG Statistical Center, Fred Hutchinson Cancer Center, Seattle, Washington.
Chen H; Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Manyam GC; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kumar G; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lazcano R; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Marques-Piubelli ML; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Laberiano-Fernandez C; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rojas F; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Zhang B; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Taing L; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts.
Jhaveri A; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts.
Geisberg J; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts.
Altreuter J; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts.
Michor F; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts.
Provencher J; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts.
Yu J; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cerami E; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts.
Moravec R; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.
Kannan K; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Luthra R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Alatrash G; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer, Houston, Texas.
Huang HH; Precision Immunology Institute, Mount Sinai, New York, New York.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
Xie H; Precision Immunology Institute, Mount Sinai, New York, New York.
Patel M; Precision Immunology Institute, Mount Sinai, New York, New York.
Nie K; Precision Immunology Institute, Mount Sinai, New York, New York.
Harris J; Precision Immunology Institute, Mount Sinai, New York, New York.
Argueta K; Precision Immunology Institute, Mount Sinai, New York, New York.
Lindsay J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
Biswas R; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
Van Nostrand S; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
Kim-Schulze S; Department of Oncological Sciences, Mount Sinai, New York, New York.; Tisch Cancer Institute, Mount Sinai, New York, New York.; Precision Immunology Institute, Mount Sinai, New York, New York.; Icahn School of Medicine at Mount Sinai, New York, New York.
Gray JE; Moffitt Cancer Caner, Tampa, Florida.
Herbst RS; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
Wistuba II; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gettinger S; Moffitt Cancer Caner, Tampa, Florida.
Kelly K; International Association for the Study of Lung Cancer, Denver, Colorado.
Bazhenova L; University of California San Diego Moores Cancer Center, La Jolla, California.
Gnjatic S; Department of Oncological Sciences, Mount Sinai, New York, New York.; Tisch Cancer Institute, Mount Sinai, New York, New York.; Precision Immunology Institute, Mount Sinai, New York, New York.; Icahn School of Medicine at Mount Sinai, New York, New York.
Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Zhang J; Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Haymaker C; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
DB Label
Database : MEDLINE
원문보기
Full Text (AACR)  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
5
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy. 미리보기

학술저널

issue
Cancer cell [Cancer Cell] 2024 Jan 08; Vol. 42 (1), pp. 35-51.e8. Date of Electronic Publication: 2023 Dec 21.
Author
Kaczanowska S; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Murty T; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Alimadadi A; La Jolla Institute for Immunology, La Jolla, CA, USA; Immunology Center of Georgia, Augusta University, Augusta, GA, USA; Georgia Cancer Center, Medical College of Georgia at Augusta University, Augusta, GA, USA.
Contreras CF; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Department of Oncology, University of Oxford, Oxford, UK.
Duault C; Stanford Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, CA, USA.
Subrahmanyam PB; Stanford Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, CA, USA.
Reynolds W; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Gutierrez NA; La Jolla Institute for Immunology, La Jolla, CA, USA.
Baskar R; Department of Pathology, Stanford University, Stanford, CA, USA.
Wu CJ; Broad Institute, Cambridge, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA.
Michor F; Broad Institute, Cambridge, MA, USA.
Altreuter J; Broad Institute, Cambridge, MA, USA.
Liu Y; Broad Institute, Cambridge, MA, USA.
Jhaveri A; Broad Institute, Cambridge, MA, USA.
Duong V; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Anbunathan H; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Ong C; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Zhang H; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Moravec R; Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Yu J; Dana-Farber Cancer Institute, Boston, MA, USA.
Biswas R; Dana-Farber Cancer Institute, Boston, MA, USA.
Van Nostrand S; Dana-Farber Cancer Institute, Boston, MA, USA.
Lindsay J; Dana-Farber Cancer Institute, Boston, MA, USA.
Pichavant M; Immunology Center of Georgia, Augusta University, Augusta, GA, USA.
Sotillo E; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Bernstein D; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Carbonell A; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Derdak J; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Klicka-Skeels J; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Segal JE; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Dombi E; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Harmon SA; Artificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Turkbey B; Artificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Sahaf B; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Bendall S; Georgia Cancer Center, Medical College of Georgia at Augusta University, Augusta, GA, USA.
Maecker H; Immunology Center of Georgia, Augusta University, Augusta, GA, USA.
Highfill SL; Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, USA.
Stroncek D; Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, USA.
Glod J; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Merchant M; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Hedrick CC; La Jolla Institute for Immunology, La Jolla, CA, USA; Immunology Center of Georgia, Augusta University, Augusta, GA, USA; Georgia Cancer Center, Medical College of Georgia at Augusta University, Augusta, GA, USA.
Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Ramakrishna S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: ramakrs@stanford.edu.
Kaplan RN; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: rosie.kaplan@nih.gov.
DB Label
Database : MEDLINE
원문보기
조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
1 
바구니보기

QUICK LINK

  • 희망도서신청
  • 대출/연장조회
  • 서가부재도서
  • 이용교육

마이메뉴추가

QRCode
  • 개인정보호정책
  • 이메일무단수집거부
  • 도서관이용문의

    • 도서관자치위원회  원격제어  Instagram  facebook  w  kakao 플친
500-757 광주광역시 북구 용봉로 77 TEL 062)530-3571~2(대출반납실) FAX 062)530-3529
Copyright@2013 CHONNAM NATIONAL UNIVERSITY LIBRARY, All Rights Reserved.
  • 82793
  • 130014372